iMEDicare are pleased to introduce Novoglan, an evidence-based, non-surgical solution for adult phimosis, now available as a reimbursable outpatient treatment under the NHS OPCS-4 code N30.5 (Stretching of the Prepuce), which maps to HRG LB56A. This presents an exciting opportunity for hospitals to offer an effective first-line treatment while benefiting from NHS reimbursement.
With proven clinical success, strong patient satisfaction, and financial viability, Novoglan is a compelling alternative to circumcision and an excellent addition to your phimosis treatment pathway, requiring just 30 minutes of patient time per day over 6-18 weeks.
Novoglan-01 clinical trial indicates 90% efficacy with all patients achieving full foreskin retraction after treatment. Similarly, 95% of patients were moderately-to-very satisfied and would recommend Novoglan to others. No adverse events were observed.
2 Year Follow-up CONCLUSIONS
The effects of Novoglan treatment persisted in all but one patient (who did not require circumcision) two years on from the Novoglan-01 clinical trial, highlighting the potential of the Novoglan treatment as a safe and effective alternative to circumcision for physiological phimosis or moderate BXO / lichen planus.
For more information:
https://www.mypelvichealth.co.uk/en/men/erectile-penile-health/
novoglan-phimosis-management/why-use-novoglan/
FURTHER INFORMATION:
iMEDicare – Pelvic Health Naturally
T: +44 (0)1923 23 77 95
E: info@mypelvichealth.co.uk
W: www.MyPelvicHealth.co.uk
